Yamagami T, Kato T, Hirota T, Yoshimatsu R, Matsumoto T, Nishimura T
Department of Radiology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Acta Radiol. 2006 Oct;47(8):775-9. doi: 10.1080/02841850600854910.
To evaluate the efficacy of hepatic port-catheter system placement without distal catheter tip occlusion or gastroduodenal artery embolization distal to the catheter tip.
A port-catheter system was percutaneously implanted in 29 patients (16 men, 13 women; mean age 65.6 years) with unresectable liver cancer. Persistent blood flow through the end hole of the catheter was verified immediately and 1-10 days after catheter placement.
In all cases, percutaneous port-catheter placement was successfully performed. In seven of 29 (24.1%) patients, flow through the end hole of the catheter was verified immediately after the procedure. However, no flow was seen 1-10 days after the procedure.
It is not necessary to occlude the end hole of the catheter tip and embolize the gastroduodenal artery beyond the catheter tip when placing a port-catheter system for repeated hepatic arterial infusion chemotherapy.
评估在不进行导管尖端远端闭塞或导管尖端远端胃十二指肠动脉栓塞的情况下放置肝门静脉导管系统的疗效。
对29例(16例男性,13例女性;平均年龄65.6岁)不可切除肝癌患者经皮植入门静脉导管系统。在导管放置后即刻以及1 - 10天,确认导管末端孔有持续血流。
所有病例均成功进行了经皮门静脉导管放置。29例患者中有7例(24.1%)在术后即刻确认有血流通过导管末端孔。然而,术后1 - 10天未见血流。
在放置门静脉导管系统用于重复肝动脉灌注化疗时,无需闭塞导管尖端的末端孔以及栓塞导管尖端以外的胃十二指肠动脉。